Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Wen, Patrick
Item TypeName
Academic Article Glioma therapy in adults.
Academic Article Durable response of a radiation-induced, high-grade cerebellar glioma to temozolomide.
Academic Article Lonafarnib (SCH66336) improves the activity of temozolomide and radiation for orthotopic malignant gliomas.
Academic Article Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells.
Academic Article Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide.
Academic Article A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme.
Academic Article Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role?
Academic Article Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study.
Academic Article International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors.
Academic Article Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study.
Academic Article Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study.
Academic Article Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03.
Academic Article Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma.
Academic Article DNA repair enzyme expression and differential response to temozolomide in a patient with both glioblastoma and metastatic pancreatic neuroendocrine tumor.
Academic Article Hepatitis B reactivation during glioblastoma treatment with temozolomide: a cautionary note.
Academic Article Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression.
Academic Article Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults.
Academic Article Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastoma.
Academic Article A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma.
Academic Article Initial treatment patterns over time for anaplastic oligodendroglial tumors.
Academic Article Phase II study of protracted daily temozolomide for low-grade gliomas in adults.
Academic Article Neurological adverse effects caused by cytotoxic and targeted therapies.
Concept Dacarbazine
Academic Article RTOG 0913: a phase 1 study of daily everolimus (RAD001) in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.
Academic Article Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.
Academic Article Enhancing radiation therapy for patients with glioblastoma.
Academic Article Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation.
Academic Article Low incidence of pseudoprogression by imaging in newly diagnosed glioblastoma patients treated with cediranib in combination with chemoradiation.
Academic Article Targeted therapies: Further delineating bevacizumab's response spectrum.
Academic Article The role of cytotoxic chemotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.
Academic Article Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients.
Academic Article Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for temozolomide.
Academic Article Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma.
Academic Article A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients.
Academic Article Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas.
Academic Article Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas.
Academic Article Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients.
Academic Article How can we develop therapies for glioblastoma more efficiently? Randomized versus single-arm studies.
Academic Article A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913.
Academic Article A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma.
Search Criteria
  • Dacarbazine
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.